Bridgewater Associates, LP

Position in EXEL — Exelixis, Inc.

CIK 1350694 Westport, CT

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,810,738

+$1,180,820 QoQ

Shares Held

400,859

-16.7% QoQ

Ownership

0.162%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#87

of 754 holders

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Bridgewater Associates, LP holds $347,338,125 across 26 Biotechnology names. EXEL ranks #7 (6.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	455,392	$48,553,895
2	HALO	Halozyme Therapeutics, Inc.	463,146	$36,250,437
3	BBIO	BridgeBio Pharma, Inc.	448,143	$33,377,690
4	REGN	Regeneron Pharmaceuticals, Inc.	51,333	$32,008,178
5	ALNY	Alnylam Pharmaceuticals, Inc.	99,584	$29,977,771
6	TGTX	Tg Therapeutics, Inc.	429,904	$23,618,925
7	EXEL	Exelixis, Inc. This page	400,859	$21,810,738
8	KRYS	Krystal Biotech, Inc.	54,489	$20,251,926

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,810,738	400,859	-16.7%	Shares	Sole	2026-08-14
2026-03-31	$20,629,918	480,996	-48.0%	Shares	Sole	2026-05-15
2025-12-31	$40,573,956	925,712	+9.8%	Shares	Sole	2026-02-13
2025-09-30	$34,814,454	842,965	+3940.1%	Shares	Sole	2025-11-13
2025-06-30	$919,729	20,865	+150.9%	Shares	Sole	2025-08-13
2025-03-31	$306,989	8,315	-52.0%	Shares	Sole	2025-05-14
2022-12-31	$277,844	17,322	-20.6%	Shares	Sole	2023-02-13
2022-06-30	$454,042	21,808	+29.4%	Shares	Sole	2022-08-11
2022-03-31	$381,921	16,847	+0.2%	Shares	Sole	2022-05-13
2021-06-30	$306,478	16,821	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.